Interspinous Spacers Market -27% of Growth to Originate from North America | Evolving Opportunities with Boston Scientific Corp., Globus Medical Inc. & Johnson, and Johnson | 17000+ Technavio Reports

NEW YORK, Feb. 28, 2022 /PRNewswire/ — The “Interspinous Spacers Market – Competitive Analysis, Drivers, Trends, Challenges, and  Five Force Analysis” report has been added to Technavio’s offering. 27% of the market’s growth will originate from North America during the forecast period. The US is the key market for interspinous spacers market in North America. Market growth in this region will be slower than the growth of the market in other regions. An expanding geriatric population with degenerative disc diseases and lumbar spinal stenosis will facilitate the interspinous spacers market growth in North America over the forecast period. The interspinous spacers market size is expected to increase by USD 18.52 million. However, the growth momentum is likely to decelerate at a CAGR of 4.09% from 2021 to 2026, as per the latest market report by Technavio.

For more insights on the market share of various regions – Download a free sample now!

Company Profiles

The interspinous spacers market is fragmented and the vendors are deploying growth strategies such as mergers and acquisitions and new product development to compete in the market. The interspinous spacers market report includes information on the product launches, sustainability, and prospects of leading vendors including Boston Scientific Corp., Globus Medical Inc., Johnson and Johnson, Life Spine Inc., Medtronic Plc, Mikai SpA, Minimus Spine Inc., Nuvasive Inc., Surgalign Holdings Inc., and Zimmer Biomet Holdings Inc.

Few companies with key offerings

  • Boston Scientific Corp. – The company offers interspinous spacers that provide solutions such as defibrillators, left atrial appendage closure, pacemakers, remote patients, monitoring and diagnostic monitoring, single-use scopes, spinal cord stimulator systems, stents.
  • Globus Medical Inc. – The company offers interspinous spacers that provide solutions such as anterior cervical. Anterior lumbar, lateral lumbar, motion preservation, posterior cervical, posterior lumbar, sacroiliac joint fixation, spinous process fixation, vertebral augmentation, vertebral body replacement.
  • Johnson and Johnson – The company offers interspinous spacers that provide solutions for Arrhythmias, Neurovascular, and Stroke.
  • Life Spine Inc. – The company offers interspinous spacers that provides procedural solutions for cervical, expandable, lateral, interbody, mis, osseoloc, si fixation, thoracolumbar.
  • Medtronic Plc – The company offers interspinous spacers that are used in treatments such as balloon kyphoplasty for spinal fractures, bone grafting, bone tumor treatment, cervical disc, replacement, cervical fusion, living with scoliosis, sacroiliac joint fusion, spinal cord stimulation for chronic pain, spinal surgical robotics.
  • To know about all major vendors with their key offerings – Download a free sample now!

Market Dynamics

Factors such as the rising prevalence of spinal disorders, the growing number of product launches will be crucial in driving the growth of the market. However, the high costs associated with spine surgery will restrict the market growth. The holistic analysis of the drivers & challenges will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Competitive Analysis

The competitive scenario provided in the interspinous spacers market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

Market Segmentation Analysis

  • By Product, the market is classified into segments static and dynamic.
  • By Geography, the market is classified as North America, Europe, APAC, South America, and MEA.

Related Reports
Wavefront Aberrometer Market –The wavefront aberrometer market share is expected to increase by USD 141.85 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.86%. Download a free sample now!

Synoptophore Market –The synoptophore market share is expected to increase by USD 62.28 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 5.09%. Download a free sample now!

Interspinous Spacers Market Scope
Report CoverageDetails
Page number120
Base year2021
Forecast period2022-2026
Growth momentum & CAGRDecelerate at a CAGR of 4.09%
Market growth 2022-2026USD 18.52 million
Market structureFragmented
YoY growth (%)4.43
Performing market contributionNorth America at 27%
Competitive landscapeLeading companies, competitive strategies, consumer engagement scope
Companies profiledBoston Scientific Corp., Globus Medical Inc., Johnson and Johnson, Life Spine Inc., Medtronic Plc, Mikai SpA, Minimus Spine Inc., Nuvasive Inc., Surgalign Holdings Inc., and Zimmer Biomet Holdings Inc.
Market DynamicsParent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period.
Customization purviewIf our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Content

1. Executive Summary                           

                1.1 Market Overview

2. Market Landscape                             

                2.1 Market ecosystem             

                                2.1.1    Parent market

                                Exhibit 08:   Parent market

                                Exhibit 09:  Market Characteristics

                2.2 Value chain analysis           

                                Exhibit 10:  Value chain analysis: Healthcare Equipment

                                2.2.1    Research and development

                                2.2.2    Inputs

                                2.2.3    Operations

                                2.2.4    Distribution

                                2.2.5    Marketing and sales

                                2.2.6    Post-sales and services

                                2.2.7    Industry innovations

3. Market Sizing                       

                3.1 Market definition

                                Exhibit 11:   Offerings of vendors included in the market definition

                3.2 Market segment analysis 

                                Exhibit 12:   Market segments

                3.3 Market size 2021 

                3.4 Market outlook: Forecast for 2021 – 2026 

                                3.4.1    Estimating growth rates for emerging and high-growth markets

                                3.4.2    Estimating growth rates for mature markets

                                Exhibit 13:  Global – Market size and forecast 2021 – 2026 ($ million)

                                Exhibit 14:  Global market: Year-over-year growth 2021 – 2026 (%)

4. Five Forces Analysis                          

                4.1 Five Forces Summary        

                                Exhibit 15: Five forces analysis 2021 & 2026

                4.2 Bargaining power of buyers           

                                Exhibit 16: Bargaining power of buyers

                4.3 Bargaining power of suppliers       

                                Exhibit 17: Bargaining power of suppliers

                4.4 Threat of new entrants    

                                Exhibit 18: Threat of new entrants

                4.5 Threat of substitutes         

                                Exhibit 19: Threat of substitutes

                4.6 Threat of rivalry   

                                Exhibit 20: Threat of rivalry

                4.7 Market condition

                                Exhibit 21:  Market condition – Five forces 2021

5. Market Segmentation by Product               

                5.1 Market segments

                                The segments covered in this chapter are:

  • Static
  • Dynamic

             Exhibit 22:  Product – Market share 2021-2026 (%)

                5.2     Comparison by Product

                                Exhibit 23:  Comparison by Product

                5.3     Static – Market size and forecast 2021-2026          

                                Exhibit 24:  Static – Market size and forecast 2021-2026 ($ million)

                                Exhibit 25:  Static – Year-over-year growth 2021-2026 (%)

                5.4     Dynamic – Market size and forecast 2021-2026    

                                Exhibit 26:  Dynamic – Market size and forecast 2021-2026 ($ million)

                                Exhibit 27:  Dynamic – Year-over-year growth 2021-2026 (%)

                5.5     Market opportunity by Product 

                                Exhibit 28:  Market opportunity by Product

6. Customer landscape                         

                6.1     Overview           

                                Exhibit 29:  Customer landscape

7. Geographic Landscape                     

                7.1 Geographic segmentation

                                The regions covered in the report are:

  • North America
  • Europe
  • APAC
  • South America
  • MEA

                                Exhibit 30:  Market share by geography 2021-2026 (%)

                7.2 Geographic comparison   

                                Exhibit 31:  Geographic comparison

                7.3     North America – Market size and forecast 2021-2026        

                                Exhibit 32:  North America – Market size and forecast 2021-2026 ($ million)

                                Exhibit 33:  North America – Year-over-year growth 2021-2026 (%)

                7.4     Europe – Market size and forecast 2021-2026       

                                Exhibit 34:  Europe – Market size and forecast 2021-2026 ($ million)

                                Exhibit 35:  Europe – Year-over-year growth 2021-2026 (%)

                7.5     APAC – Market size and forecast 2021-2026          

                                Exhibit 36:  APAC – Market size and forecast 2021-2026 ($ million)

                                Exhibit 37:  APAC – Year-over-year growth 2021-2026 (%)

                7.6     South America – Market size and forecast 2021-2026        

                                Exhibit 38:  South America – Market size and forecast 2021-2026 ($ million)

                                Exhibit 39:  South America – Year-over-year growth 2021-2026 (%)

                7.7     MEA – Market size and forecast 2021-2026           

                                Exhibit 40:  MEA – Market size and forecast 2021-2026 ($ million)

                                Exhibit 41:  MEA – Year-over-year growth 2021-2026 (%)

                7.8     Key leading countries    

                                Exhibit 42:  Key leading countries

                7.9     Market opportunity by geography           

                                Exhibit 43:  Market opportunity by geography ($ million)

8. Drivers, Challenges, and Trends                   

                8.1 Market drivers     

                                8.1.1    Rising prevalence of spinal disorders

                                8.1.2    Growing number of product launches

                                8.1.3    Strategic business partnerships

                8.2 Market challenges              

                                8.2.1    High costs associated with spine surgery

                                8.2.2    Availability of alternate medication options

                                8.2.3    Risks associated with interventional spine procedures

                                Exhibit 44:  Impact of drivers and challenges

                8.3 Market trends      

                                8.3.1    Technological advances

                                8.3.2    Presence of contract manufacturers

                                8.3.3    Increasing adoption rate of minimally invasive surgeries

9. Vendor Landscape                             

                9.1     Overview           

                                Exhibit 45:  Vendor landscape

                9.2     Landscape disruption    

                                Exhibit 46:  Landscape disruption

                                Exhibit 47:  Industry risks

                9.3     Competitive landscape 

10. Vendor Analysis               

                10.1 Vendors covered              

                                Exhibit 48:  Vendors covered

                10.2 Market positioning of vendors    

                                Exhibit 49:  Market positioning of vendors

                10.3  Boston Scientific Corp.  

                                Exhibit 50:  Boston Scientific Corp. – Overview

                                Exhibit 51:  Boston Scientific Corp. – Business segments

                                Exhibit 52:  Boston Scientific Corp. – Key offerings

                                Exhibit 53:  Boston Scientific Corp. – Segment focus

                10.4  Globus Medical Inc.        

                                Exhibit 54:  Globus Medical Inc. – Overview

                                Exhibit 55:  Globus Medical Inc. – Product and service

                                Exhibit 56:  Globus Medical Inc. – Key offerings

                10.5  Johnson and Johnson    

                                Exhibit 57:  Johnson and Johnson – Overview

                                Exhibit 58:  Johnson and Johnson – Business segments

                                Exhibit 59:  Johnson and Johnson – Key offerings

                                Exhibit 60:  Johnson and Johnson – Segment focus

                10.6  Life Spine Inc.   

                                Exhibit 61:  Life Spine Inc.  – Overview

                                Exhibit 62:  Life Spine Inc.  – Business segments

                                Exhibit 63:  Life Spine Inc.  – Key offerings

                                Exhibit 64:  Life Spine Inc.  – Segment focus

                10.7  Medtronic Plc   

                                Exhibit 65:  Medtronic Plc – Overview

                                Exhibit 66:  Medtronic Plc – Business segments

                                Exhibit 67:  Medtronic Plc – Key offerings

                                Exhibit 68:  Medtronic Plc – Segment focus

                10.8  Mikai SpA           

                                Exhibit 69:  Mikai SpA – Overview

                                Exhibit 70:  Mikai SpA – Product and service

                                Exhibit 71:  Mikai SpA – Key offerings

                10.9  Minimus Spine Inc.         

                                Exhibit 72:  Minimus Spine Inc. – Overview

                                Exhibit 73:  Minimus Spine Inc. – Product and service

                                Exhibit 74:  Minimus Spine Inc. – Key offerings

                10.10                Nuvasive Inc.    

                                Exhibit 75:  Nuvasive Inc. – Overview

                                Exhibit 76:  Nuvasive Inc. – Business segments

                                Exhibit 77:  Nuvasive Inc. – Key news

                                Exhibit 78:  Nuvasive Inc. – Key offerings

                                Exhibit 79:  Nuvasive Inc. – Segment focus

                10.11                Surgalign Holdings Inc.  

                                Exhibit 80:  Surgalign Holdings Inc. – Overview

                                Exhibit 81:  Surgalign Holdings Inc. – Business segments

                                Exhibit 82:  Surgalign Holdings Inc. – Key offerings

                                Exhibit 83:  Surgalign Holdings Inc. – Segment focus

                10.12                Zimmer Biomet Holdings Inc.     

                                Exhibit 84:  Zimmer Biomet Holdings Inc. – Overview

                                Exhibit 85:  Zimmer Biomet Holdings Inc. – Business segments

                                Exhibit 86:  Zimmer Biomet Holdings Inc. – Key offerings

                                Exhibit 87:  Zimmer Biomet Holdings Inc. – Segment focus

11. Appendix                            

                11.1 Scope of the report         

                                11.1.1 Market definition

                                11.1.2 Objective

                                11.1.3 Notes and caveats

                11.2 Currency conversion rates for US$            

                                Exhibit 88:  Currency conversion rates for US$

                11.3 Research Methodology 

                                Exhibit 89:  Research Methodology

                                Exhibit 90:  Validation techniques employed for market sizing

                                Exhibit 91:  Information sources

                11.4 List of abbreviations        

                                Exhibit 92:  List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200

SOURCE Technavio

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button